1. Home
  2. TRVI vs USCB Comparison

TRVI vs USCB Comparison

Compare TRVI & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • USCB
  • Stock Information
  • Founded
  • TRVI 2011
  • USCB 2002
  • Country
  • TRVI United States
  • USCB United States
  • Employees
  • TRVI N/A
  • USCB N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • USCB Major Banks
  • Sector
  • TRVI Health Care
  • USCB Finance
  • Exchange
  • TRVI Nasdaq
  • USCB Nasdaq
  • Market Cap
  • TRVI 383.4M
  • USCB 366.2M
  • IPO Year
  • TRVI 2019
  • USCB 2021
  • Fundamental
  • Price
  • TRVI $6.50
  • USCB $18.66
  • Analyst Decision
  • TRVI Strong Buy
  • USCB Buy
  • Analyst Count
  • TRVI 8
  • USCB 2
  • Target Price
  • TRVI $17.56
  • USCB $18.25
  • AVG Volume (30 Days)
  • TRVI 4.4M
  • USCB 38.1K
  • Earning Date
  • TRVI 03-18-2025
  • USCB 04-24-2025
  • Dividend Yield
  • TRVI N/A
  • USCB 1.35%
  • EPS Growth
  • TRVI N/A
  • USCB 47.62
  • EPS
  • TRVI N/A
  • USCB 1.24
  • Revenue
  • TRVI N/A
  • USCB $79,519,000.00
  • Revenue This Year
  • TRVI N/A
  • USCB $22.51
  • Revenue Next Year
  • TRVI N/A
  • USCB $7.69
  • P/E Ratio
  • TRVI N/A
  • USCB $15.10
  • Revenue Growth
  • TRVI N/A
  • USCB 25.02
  • 52 Week Low
  • TRVI $2.30
  • USCB $10.25
  • 52 Week High
  • TRVI $7.39
  • USCB $21.86
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 66.37
  • USCB 49.27
  • Support Level
  • TRVI $6.22
  • USCB $18.60
  • Resistance Level
  • TRVI $6.79
  • USCB $19.25
  • Average True Range (ATR)
  • TRVI 0.40
  • USCB 0.50
  • MACD
  • TRVI -0.03
  • USCB 0.05
  • Stochastic Oscillator
  • TRVI 52.24
  • USCB 55.46

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About USCB USCB Financial Holdings Inc.

USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.

Share on Social Networks: